HealthEquity, Inc. (NASDAQ:HQY) Receives Average Rating of “Buy” from Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY) have received a consensus recommendation of “Buy” from the eleven analysts that are presently covering the firm, Marketbeat Ratings reports. Eleven research analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $96.17.

A number of equities analysts have recently issued reports on the company. Royal Bank of Canada increased their target price on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, March 20th. Barrington Research reissued an “outperform” rating and set a $100.00 price objective on shares of HealthEquity in a report on Friday, March 22nd. BTIG Research boosted their target price on shares of HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. KeyCorp increased their target price on shares of HealthEquity from $85.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, March 22nd. Finally, JMP Securities initiated coverage on shares of HealthEquity in a research report on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 price target on the stock.

Insiders Place Their Bets

In other news, EVP Delano Ladd sold 2,558 shares of HealthEquity stock in a transaction on Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the completion of the sale, the executive vice president now directly owns 47,438 shares of the company’s stock, valued at approximately $3,917,904.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other HealthEquity news, EVP Delano Ladd sold 2,558 shares of the company’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $82.59, for a total transaction of $211,265.22. Following the transaction, the executive vice president now directly owns 47,438 shares in the company, valued at approximately $3,917,904.42. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jon Kessler sold 33,765 shares of HealthEquity stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the sale, the chief executive officer now owns 126,635 shares of the company’s stock, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. In the last quarter, insiders have sold 71,322 shares of company stock valued at $5,682,895. 2.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Cape Investment Advisory Inc. bought a new stake in HealthEquity in the fourth quarter valued at about $27,000. Rise Advisors LLC acquired a new stake in shares of HealthEquity in the 1st quarter valued at approximately $28,000. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $29,000. YHB Investment Advisors Inc. bought a new position in HealthEquity during the 1st quarter worth approximately $40,000. Finally, DekaBank Deutsche Girozentrale acquired a new position in HealthEquity during the third quarter valued at approximately $41,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Trading Up 0.0 %

Shares of HealthEquity stock opened at $80.30 on Tuesday. HealthEquity has a 52-week low of $48.86 and a 52-week high of $84.49. The firm has a market capitalization of $6.89 billion, a PE ratio of 125.47, a price-to-earnings-growth ratio of 1.31 and a beta of 0.53. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.76. The company’s fifty day moving average price is $81.01 and its two-hundred day moving average price is $74.49.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.08. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. The business had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. On average, analysts expect that HealthEquity will post 2.12 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.